Summary analysis of the phase 1a/b study with HBI0101, an academic anti-BCMA chimeric antigen receptor T-cell (CART) for relapsed/refractory multiple myeloma

Eyal Lebel; Nathalie Asherie; Shlomit Kfir-Erenfeld; Batia Avni; Sigal Grisariu; Shlomo Elias; Eran Zimran; Vladimir Vainstein; Shlomzion Aumann; Miri Assayag; Marina Krizhevskaya; Ekaterina Dikhter; Marjorie Pick; Yael Cohen; Irit Avivi; Cyrille Cohen; Moshe Gatt; Polina Stepensky

doi:10.1182/blood-2025-2379

Summary analysis of the phase 1a/b study with HBI0101, an academic anti-BCMA chimeric antigen receptor T-cell (CART) for relapsed/refractory multiple myeloma

Eyal Lebel
, Nathalie Asherie
, Shlomit Kfir-Erenfeld
, Batia Avni
, Sigal Grisariu
, Shlomo Elias
, Eran Zimran
, Vladimir Vainstein
, Shlomzion Aumann
, Miri Assayag
, Marina Krizhevskaya
, Ekaterina Dikhter
, Marjorie Pick
, Yael Cohen
, Irit Avivi
, Cyrille Cohen
, Moshe Gatt
, Polina Stepensky

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	2379-2380
Number of pages	2
Journal	Blood
Volume	146
DOIs	https://doi.org/10.1182/blood-2025-2379
State	Published - 3 Nov 2025

Access to Document

10.1182/blood-2025-2379

https://ashpublications.org/blood/article-pdf/146/Supplement%201/2379/2445403/blood-5126-main.pdf

Cite this

Lebel, E., Asherie, N., Kfir-Erenfeld, S., Avni, B., Grisariu, S., Elias, S., Zimran, E., Vainstein, V., Aumann, S., Assayag, M., Krizhevskaya, M., Dikhter, E., Pick, M., Cohen, Y., Avivi, I., Cohen, C., Gatt, M., & Stepensky, P. (2025). Summary analysis of the phase 1a/b study with HBI0101, an academic anti-BCMA chimeric antigen receptor T-cell (CART) for relapsed/refractory multiple myeloma. Blood, 146, 2379-2380. https://doi.org/10.1182/blood-2025-2379

@article{6d45bbaef0e841f68a8092497e3f9c91,

title = "Summary analysis of the phase 1a/b study with HBI0101, an academic anti-BCMA chimeric antigen receptor T-cell (CART) for relapsed/refractory multiple myeloma",

author = "Eyal Lebel and Nathalie Asherie and Shlomit Kfir-Erenfeld and Batia Avni and Sigal Grisariu and Shlomo Elias and Eran Zimran and Vladimir Vainstein and Shlomzion Aumann and Miri Assayag and Marina Krizhevskaya and Ekaterina Dikhter and Marjorie Pick and Yael Cohen and Irit Avivi and Cyrille Cohen and Moshe Gatt and Polina Stepensky",

year = "2025",

month = nov,

day = "3",

doi = "10.1182/blood-2025-2379",

language = "אנגלית",

volume = "146",

pages = "2379--2380",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

}

Lebel, E, Asherie, N, Kfir-Erenfeld, S, Avni, B, Grisariu, S, Elias, S, Zimran, E, Vainstein, V, Aumann, S, Assayag, M, Krizhevskaya, M, Dikhter, E, Pick, M, Cohen, Y, Avivi, I, Cohen, C, Gatt, M & Stepensky, P 2025, 'Summary analysis of the phase 1a/b study with HBI0101, an academic anti-BCMA chimeric antigen receptor T-cell (CART) for relapsed/refractory multiple myeloma', Blood, vol. 146, pp. 2379-2380. https://doi.org/10.1182/blood-2025-2379

TY - JOUR

T1 - Summary analysis of the phase 1a/b study with HBI0101, an academic anti-BCMA chimeric antigen receptor T-cell (CART) for relapsed/refractory multiple myeloma

AU - Lebel, Eyal

AU - Asherie, Nathalie

AU - Kfir-Erenfeld, Shlomit

AU - Avni, Batia

AU - Grisariu, Sigal

AU - Elias, Shlomo

AU - Zimran, Eran

AU - Vainstein, Vladimir

AU - Aumann, Shlomzion

AU - Assayag, Miri

AU - Krizhevskaya, Marina

AU - Dikhter, Ekaterina

AU - Pick, Marjorie

AU - Cohen, Yael

AU - Avivi, Irit

AU - Cohen, Cyrille

AU - Gatt, Moshe

AU - Stepensky, Polina

PY - 2025/11/3

Y1 - 2025/11/3

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=barilanwos&SrcAuth=WosAPI&KeyUT=WOS:001660598000029&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1182/blood-2025-2379

DO - 10.1182/blood-2025-2379

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.abstract???

SN - 0006-4971

VL - 146

SP - 2379

EP - 2380

JO - Blood

JF - Blood

ER -

Summary analysis of the phase 1a/b study with HBI0101, an academic anti-BCMA chimeric antigen receptor T-cell (CART) for relapsed/refractory multiple myeloma

Access to Document

Other files and links

Cite this